<DOC>
	<DOCNO>NCT00747903</DOCNO>
	<brief_summary>RATIONALE : Photodynamic therapy use drug becomes active expose certain kind light . When drug active , tumor cell kill . This may effective treatment skin cancer . PURPOSE : This phase II trial study side effect photodynamic therapy use aminolevulinic acid see well work treat patient skin cancer .</brief_summary>
	<brief_title>Photodynamic Therapy Using Aminolevulinic Acid Treating Patients With Skin Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine safety efficacy intralesional photodynamic therapy use aminolevulinic acid non-coherent blue light patient nodular basal cell carcinoma . OUTLINE : Patients undergo photodynamic therapy comprise intralesional injection aminolevulinic acid follow non-coherent blue light therapy approximately 17 minute . Patients may undergo re-treatment photodynamic therapy 8 week later . Patients undergo photographic assessment skin lesion baseline , 8 week , 16 week , 1 2 year evaluate healing time , clinical improvement , side effect . Patients undergo biopsy skin lesion 16 week 1 2 year confirm histological clearance .</detailed_description>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven basal cell carcinoma trunk extremity Tumor size ≤ 2 cm diameter PATIENT CHARACTERISTICS : Willing able comply followup requirement Mentally competent No active , localize , systemic infection Not immunocompromised No coagulation disorder No photosensitivity allergy sunlight Not pregnant nursing No history keloid formation No history cutaneous photosensitization , porphyria , hypersensitivity porphyrin , photodermatosis PRIOR CONCURRENT THERAPY : No prior gold therapy No prior radiotherapy trunk extremity More 24 month since prior oral retinoids ( e.g. , isotretinoin acitretin ) photosensitizing drug ( e.g. , Declomycin® ) More 1 year since prior collagen injection , Botox® injection , chemical peel , dermabrasion , resurface procedure More 1 month since prior topical retinoid therapy No concurrent aspirin antioxidants No concurrent anticoagulation medication</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>basal cell carcinoma skin</keyword>
	<keyword>recurrent skin cancer</keyword>
</DOC>